Safety and Toxicology of Magnolol and Honokiol
- 20 June 2018
- journal article
- research article
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 84 (16), 1151-1164
- https://doi.org/10.1055/a-0642-1966
Abstract
Magnolia officinalis and Magnolia obovata bark extracts have been used for thousands of years in Chinese and Japanese traditional medicines and are still widely employed as herbal preparations for their sedative, antioxidant, anti-inflammatory, antibiotic, and antispastic effects. Neolignans, particularly magnolol and honokiol, are the main substances responsible for the beneficial properties of the magnolia bark extract (MBE). The content of magnolol and honokiol in MBE depends on different factors, including the Magnolia plant species, the area of origin, the part of the plant employed, and the method used to prepare the extract. The biological and pharmacological activities of magnolol and honokiol have been extensively investigated. Here we review the safety and toxicological properties of magnolol and honokiol as pure substances or as components of concentrated MBE, including the potential side-effects in humans after oral intake. In vitro and in vivo genotoxicity studies indicated that concentrated MBE has no mutagenic and genotoxic potential, while a subchronic study performed according to OECD (Organisation for Economic Co-operation and Development) guidelines established a no adverse effect level for concentrated MBE > 240 mg/kg b.w/d. Similar to other dietary polyphenols, magnolol and honokiol are subject to glucuronidation, and despite a relatively quick clearance, an interaction with pharmaceutical active principles or other herbal constituents cannot be excluded. However, intervention trials employing concentrated MBE for up to 1 y did not report adverse effects. In conclusion, over the recent years different food safety authorities evaluated magnolol and honokiol and considered them safe.Keywords
This publication has 63 references indexed in Scilit:
- Effect of Honokiol on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver MicrosomesMolecules, 2013
- Identification of metabolites of honokiol in rat urine using 13C stable isotope labeling and liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometryJournal of Chromatography A, 2013
- Honokiol, a Multifunctional Antiangiogenic and Antitumor AgentAntioxidants and Redox Signaling, 2009
- Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activityJournal of Natural Medicines, 2009
- The Role of PPAR in Hepatocellular CarcinomaPPAR Research, 2008
- Effect of a proprietary Magnolia and Phellodendronextract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trialNutrition Journal, 2008
- Glucuronidation of Magnolol Assessed using HPLC/FluorescencePlanta Medica, 1995
- Isolation and Characterization of Phenolic Compounds from Magnoliae Cortex Produced in China.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Metabolism of magnolol from Magnoliae Cortex. II. Absorption, metabolism and excretion of (ring-14C)magnolol in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986